Butyrylcholinesterase K and Apolipoprotein ε4 Affect Cortical Thickness and Neuropsychiatric Symptoms in Alzheimer’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|11|2|137-144

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.11, Iss.2, 2014-02, pp. : 137-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer’s disease

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 151-155

Humana Press, Inc

Access to resources Recommend Favorite

Genetic variation in apolipoprotein D and Alzheimer’s disease

By Helisalmi S.   Hiltunen M.   Vepsäläinen S.   Iivonen S.   Corder E.   Lehtovirta M.   Mannermaa A.   Koivisto A.   Soininen H.  

Journal of Neurology, Vol. 251, Iss. 8, 2004-08 ,pp. : 951-957

Springer Publishing Company

Access to resources Recommend Favorite

Identification of Novel Quantitative Traits-Associated Susceptibility Loci for APOE ε 4 Non-Carriers of Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 12, Iss. 3, 2015-03 ,pp. : 218-227

Bentham Science Publishers

Access to resources Recommend Favorite

Prevalence of Neuropsychiatric Symptoms in Alzheimer's Disease and Vascular Dementia

By  

Current Alzheimer Research, Vol. 5, Iss. 1, 2008-02 ,pp. : 61-69

Bentham Science Publishers

Access to resources Recommend Favorite

Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer’s disease

By Frey C.   Bonert A.   Kratzsch T.   Rexroth G.   Rösch W.   Müller-Spahn F.   Maurer K.   Müller W. E.   Eckert A.  

Journal of Neural Transmission, Vol. 113, Iss. 11, 2006-11 ,pp. : 1753-1761

Springer Publishing Company

Access to resources Recommend Favorite